第28届京台科技论坛 ——未来健康创新发展对接会成功举办

Core Insights - The 28th Beijing-Taipei Technology Forum focused on the application of new productivity in the future health sector, aligning with the government's emphasis on technological innovation to drive industrial innovation [2][5] - Key discussions included advancements in gene technology, cell therapy, brain science, artificial intelligence in healthcare, and synthetic biology, aiming to enhance collaboration and technology transfer between Beijing and Taipei [2][5] Group 1: Event Overview - The event was attended by nearly 200 experts, scholars, and business representatives from both regions, highlighting the importance of cross-strait collaboration in health technology [2][6] - Prominent speakers included academicians who presented on topics such as AI in medical diagnostics and the integration of traditional and Western medicine in cancer treatment [2][3] Group 2: Strategic Collaborations - Multiple strategic partnerships were formed, including collaborations between Mei Ya Health Longevity Clinic and Beijing-based institutions on cell technology, and various agreements focused on investment and project implementation [4] - The signed agreements cover diverse areas such as technology co-research, industry incubation, market application, and financial support, showcasing the depth of integration between health technology resources from both regions [4] Group 3: Policy and Support Framework - Recent government policies, including the draft regulations on biomedical new technology clinical research, provide a solid institutional framework for the innovative and regulated development of the health industry [5] - Beijing's initiatives, such as the implementation plan for promoting future industrial innovation, emphasize significant investment in future health sectors, with a commitment to allocate no less than 20% of funding towards these areas [5]